Capital Goods Healthcare Sector

Galecto

Market Cap: US$3.9m

A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.

Kazia Therapeutics

Market Cap: US$3.9m

Operates as an oncology-focused biotechnology company in South Korea.

ALR Technologies SG

Market Cap: US$3.9m

A data management company, provides diabetes care management solutions for human and animal health diabetes.

Matinas BioPharma Holdings

Market Cap: US$3.9m

A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.

Interpace Biosciences

Market Cap: US$3.9m

Provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States.

Zelira Therapeutics

Market Cap: AU$5.9m

A biopharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of a variety of medical conditions in Australia and the United States.

MYND Life Sciences

Market Cap: CA$5.2m

A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.

InhaleRx

Market Cap: AU$5.8m

A biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia.

Willow Biosciences

Market Cap: CA$5.1m

Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

Filament Health

Market Cap: US$3.7m

Operates as a clinical-stage natural psychedelic drug development company in Canada.

Avricore Health

Market Cap: CA$5.1m

Engages in the health data and point-of-care technologies business.

Palatin Technologies

Market Cap: US$3.7m

A biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States.

Tharimmune

Market Cap: US$3.6m

A clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States.

Aion Therapeutic

Market Cap: CA$5.0m

Engages in the health and wellness business in the United States.

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

Applied DNA Sciences

Market Cap: US$3.6m

A biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally.

VivoSim Labs

Market Cap: US$3.6m

A biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.

Biodexa Pharmaceuticals

Market Cap: US$3.6m

A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.

Mystic Holdings

Market Cap: US$3.5m

Through its subsidiaries, engages in the cultivation, production, and wholesale of medical and recreational cannabis in Nevada, the United States.

Leveljump Healthcare

Market Cap: CA$4.8m

Provides radiology services.

Psykey

Market Cap: US$3.5m

Engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life.

Genetic Technologies

Market Cap: AU$5.7m

A molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

SciSparc

Market Cap: US$3.5m

A clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.

Longevity Health Holdings

Market Cap: US$3.5m

A bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products.

Roquefort Therapeutics

Market Cap: UK£2.6m

A material biotech company, engages in the development of medicines for the treatment of cancer.

Adherium

Market Cap: AU$5.3m

Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America.

Sonnet BioTherapeutics Holdings

Market Cap: US$3.4m

A biotechnology company, owns a platform for biologic medicines of single or bifunctional action.

GlucoTrack

Market Cap: US$3.4m

A medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States.

BSF Enterprise

Market Cap: UK£2.5m

Develops and commercializes cutting-edge tissue-engineered solutions.

Lixte Biotechnology Holdings

Market Cap: US$3.4m

A clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.

Enzolytics

Market Cap: US$3.4m

Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

ProtoKinetix

Market Cap: US$3.4m

A research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs).

Lobe Sciences

Market Cap: CA$4.6m

A biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada.

City View Green Holdings

Market Cap: CA$4.6m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

Palisade Bio

Market Cap: US$3.3m

A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.